4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
2.990
-0.240 (-7.43%)
Apr 1, 2025, 4:00 PM EDT - Market closed

4D Molecular Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Market Capitalization
1382578667197051,098
Upgrade
Market Cap Growth
-70.27%-70.27%20.40%2.03%-35.79%-
Upgrade
Enterprise Value
-342-2685624974781,185
Upgrade
Last Close Price
2.995.5720.2622.2121.9441.45
Upgrade
PS Ratio
3741.746959.1441.80229.9339.0980.68
Upgrade
PB Ratio
0.270.502.813.112.214.28
Upgrade
P/TBV Ratio
0.500.502.813.112.214.28
Upgrade
EV/Sales Ratio
-27.10158.8926.5087.05
Upgrade
Debt / Equity Ratio
0.050.050.050.070.05-
Upgrade
Asset Turnover
000.070.010.060.08
Upgrade
Quick Ratio
14.5814.5815.2113.5815.2116.62
Upgrade
Current Ratio
14.9214.9215.6514.0215.6916.88
Upgrade
Return on Equity (ROE)
-39.31%-39.31%-37.41%-39.06%-24.79%-39.59%
Upgrade
Return on Assets (ROA)
-26.08%-26.08%-23.45%-22.35%-13.89%-20.44%
Upgrade
Return on Capital (ROIC)
-27.38%-27.38%-24.75%-23.59%-15.06%-24.73%
Upgrade
Earnings Yield
-116.20%-62.48%-11.64%-14.94%-10.11%-5.16%
Upgrade
FCF Yield
-99.95%-53.74%-9.07%-13.65%-11.10%-4.73%
Upgrade
Buyback Yield / Dilution
-37.86%-37.86%-20.95%-16.66%-331.23%-25.05%
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q